Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

eFFECTOR Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1
Revenues  3.61.442.00.0
            Revenue growth  148.5%-96.6%  
Cost of goods sold  0.00.00.00.0
Gross profit  3.61.442.00.0
            Gross margin  100.0%100.0%100.0% 
Selling, general and administrative   [+]12.613.44.34.7
Research and development  23.320.021.823.9
EBITDA   [+]-32.4-31.916.0-28.3
            EBITDA margin  -910.5%-2228.9%38.0% 
Depreciation and amortization  0.10.00.20.3
EBIT   [+]-32.4-31.915.8-28.6
            EBIT margin  -912.0%-2230.6%37.7% 
Interest expense, net   [+]1.81.81.31.1
Other income (expense), net   [+]11.649.50.00.0
Pre-tax income  -22.715.814.6-29.7
Income taxes  0.00.00.40.0
            Tax rate  0.0%0.0%2.4%0.0%
Net income  -22.715.80.2-14.2
            Net margin  -637.9%1104.8%0.4% 
   
Basic EPS   [+]($0.55)$1.05$0.12($11.88)
Diluted EPS   [+]($0.55)$0.44$0.06($11.88)
   
Shares outstanding (basic)   [+]41.215.11.41.2
Shares outstanding (diluted)   [+]41.236.02.71.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy